Multifactorial Causation and Therapies of Myopia

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".

Deadline for manuscript submissions: 28 October 2024 | Viewed by 958

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmacy, Biotechnology, Nutrition, Optics and Optometry, Faculty of Biomedical and Health Sciences, European University of Madrid, 28670 Villaviciosa de Odón, Madrid, Spain
Interests: myopia control; irregular cornea; optical quality of the eye; refractive surgery
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Optometry and Vision, Faculty of Optics and Optometry, Universidad Complutense de Madrid, 28037 Madrid, Spain
Interests: myopia; sport vision; optometry; visual health; refractive errors; contact lenses
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Optics, Pharmacology and Anatomy, University of Alicante, 03690 Alicante, Spain
Interests: cornea; refractive surgery; cataract; ocular surface; ocular imaging
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The prevalence of myopia continues to increase and fulfills the forecasts set out years ago. According to these data, we are facing a pandemic with enormous clinical and research interest, since its comorbidities have a negative impact on public health and its financing.

This Special Issue aims to review the current situation and future prospects for myopia, from its causes to its current management and possible control.

These topics of interest include:

  • The epidemiology of myopia;
  • Theories about myopia, the role of accommodation, the retina, the choroid, and the sclera;
  • Myopia and genetics;
  • Premyopia, simple myopia, and pathological myopia;
  • The prevention of atropine and sunlight, and myopia progression risk;
  • Efficacy, predictability, and safety in short-, medium-, and long-term pharmacological and optical treatments (ophthalmic lenses, orthokeratology, and soft contact lenses), and rebound effects, application protocols, and predictors of success;
  • Light and myopia (blue light and red light in myopia control), as well as other treatments used for simple myopia and pathological myopia;
  • New and emerging myopia management strategies.
  • Binocular vision (phorias, AC/A, accommodative LAG, etc) and ocular optics (axial length, anterior and vitreous chamber, high-order aberrations, etc) in myopia
  • Artificial intelligence applied to myopia

Prof. Dr. César Villa Collar
Dr. Cristina Alvarez-Peregrina
Prof. Dr. David Piñero
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • epidemiology
  • genetics
  • premyopia
  • simple and pathological myopia
  • orthokeratology
  • lenses for myopia control
  • blue light and red light
  • binocular vision and ocular optics
  • artificial intelligence

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

9 pages, 937 KiB  
Article
Safety, Efficacy, and Visual Performance of an Orthokeratology Lens with Increased Compression Factor
by Elena Martínez-Plaza, Cecilia Zamora Castro, Ainhoa Molina-Martín and David P. Piñero
J. Clin. Med. 2024, 13(2), 587; https://doi.org/10.3390/jcm13020587 - 19 Jan 2024
Viewed by 663
Abstract
The aim was to evaluate the safety, efficacy, and visual performance of an orthokeratology lens with an increased compression factor (ICF) of 1.25 D in a 3-month follow-up. Thirty-six myopic patients (5 males and 31 females; 24.2 ± 5.8 years) were fitted with [...] Read more.
The aim was to evaluate the safety, efficacy, and visual performance of an orthokeratology lens with an increased compression factor (ICF) of 1.25 D in a 3-month follow-up. Thirty-six myopic patients (5 males and 31 females; 24.2 ± 5.8 years) were fitted with Alexa AR (Tiedra Farmacéutica S.L., Madrid, Spain) contact lenses (CLs) and twenty participants finished the follow-up. Visual acuity (VA), subjective refraction, primary spherical and primary coma aberrations, keratometry, central pachymetry, and ocular surface evaluation were performed at baseline and after 1 night, 1 week, 1 month, and 3 months of CL wear. The differences among visits were analyzed using a repeated-measures analysis of variance or the Friedman test. The spherical equivalent decreased (p ≤ 0.005), and the uncorrected VA improved (p < 0.001) until the first week. Corneal and ocular aberrations showed a significant increase (p ≤ 0.02). A significant decrease (p < 0.001) was found for keratometry values. No significant changes were observed in either central pachymetry or ocular surface parameters among study visits. In conclusion, an orthokeratology CL with an ICF of 1.25 D provides good safety, efficacy, and visual performance in a 3-month follow-up. Seven days of orthokeratology wear are enough to achieve the full myopic compensation, resulting in satisfactory VA. Full article
(This article belongs to the Special Issue Multifactorial Causation and Therapies of Myopia)
Show Figures

Figure 1

Back to TopTop